| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |